Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021

SELL
$17.37 - $27.92 $1.43 Million - $2.29 Million
-82,105 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$26.14 - $37.45 $1.55 Million - $2.22 Million
-59,245 Reduced 41.91%
82,105 $2.42 Million
Q1 2021

May 14, 2021

SELL
$23.5 - $39.58 $75,905 - $127,843
-3,230 Reduced 2.23%
141,350 $3.81 Million
Q4 2020

Feb 16, 2021

BUY
$22.55 - $30.87 $3.26 Million - $4.46 Million
144,580 New
144,580 $3.34 Million

Others Institutions Holding BNR

About Burning Rock Biotech Ltd


  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $633M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Indus Capital Partners, LLC Portfolio

Follow Indus Capital Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Indus Capital Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Indus Capital Partners, LLC with notifications on news.